Human genetic and immunological determinants of critical COVID-19 pneumonia

Q Zhang, P Bastard, A Cobat, JL Casanova - Nature, 2022 - nature.com
SARS-CoV-2 infection is benign in most individuals but, in around 10% of cases, it triggers
hypoxaemic COVID-19 pneumonia, which leads to critical illness in around 3% of cases …

[HTML][HTML] From rare disorders of immunity to common determinants of infection: Following the mechanistic thread

JL Casanova, L Abel - Cell, 2022 - cell.com
The immense interindividual clinical variability during any infection is a long-standing
enigma. Inborn errors of IFN-γ and IFN-α/β immunity underlying rare infections with weakly …

An immune-based biomarker signature is associated with mortality in COVID-19 patients

MS Abers, OM Delmonte, EE Ricotta, J Fintzi… - JCI …, 2021 - pmc.ncbi.nlm.nih.gov
Immune and inflammatory responses to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) contribute to disease severity of coronavirus disease 2019 (COVID-19) …

Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in∼ 40% of patients

A Gervais, F Rovida, MA Avanzini, S Croce… - Journal of Experimental …, 2023 - rupress.org
Mosquito-borne West Nile virus (WNV) infection is benign in most individuals but can cause
encephalitis in< 1% of infected individuals. We show that∼ 35% of patients hospitalized for …

Autoantibodies against type I IFNs in patients with critical influenza pneumonia

Q Zhang, A Pizzorno, L Miorin, P Bastard… - Journal of Experimental …, 2022 - rupress.org
Autoantibodies neutralizing type I interferons (IFNs) can underlie critical COVID-19
pneumonia and yellow fever vaccine disease. We report here on 13 patients harboring …

The ouroboros of autoimmunity

JL Casanova, J Peel, J Donadieu, AL Neehus… - Nature …, 2024 - nature.com
Human autoimmunity against elements conferring protective immunity can be symbolized by
the 'ouroboros', a snake eating its own tail. Underlying infection is autoimmunity against …

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

P Bastard, LB Rosen, Q Zhang, E Michailidis… - Science, 2020 - science.org
INTRODUCTION Interindividual clinical variability is vast in humans infected with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ranging from silent infection to …

Human autoantibodies underlying infectious diseases

A Puel, P Bastard, J Bustamante… - Journal of Experimental …, 2022 - rupress.org
The vast interindividual clinical variability observed in any microbial infection—ranging from
silent infection to lethal disease—is increasingly being explained by human genetic and …

Autoimmune polyendocrine syndromes

ES Husebye - The Rose and Mackay Textbook of Autoimmune …, 2024 - Elsevier
Autoimmune polyendocrinopathies are traditionally divided into two distinct syndromes,
autoimmune polyendocrine syndrome type 1 and 2 (APS-1 and-2). The first is a monogenic …

Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths

P Bastard, A Gervais, T Le Voyer, J Rosain… - Science …, 2021 - science.org
Circulating autoantibodies (auto-Abs) neutralizing high concentrations (10 ng/ml; in plasma
diluted 1: 10) of IFN-α and/or IFN-ω are found in about 10% of patients with critical COVID …